Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Canopy Rivers Inc. Begins Trading on the TSX Venture Exchange


Posted on: 20 Sep 18

TORONTO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (TSXV:RIV) (“Canopy Rivers” or the “Company”) is pleased to announce that effective at the opening of the market today, September 20, 2018, the Company’s subordinated voting shares will begin trading on the TSX Venture Exchange (the “TSXV”) under the ticker symbol “RIV”.

On September 17, 2018, the Company (formerly named AIM2 Ventures Inc.) announced the completion of its “Qualifying Transaction” (as such term is defined in Policy 2.4 of the TSXV Corporate Finance Manual) involving a three-cornered amalgamation, pursuant to which 10859150 Canada Inc., a wholly owned subsidiary of the Company, amalgamated with Canopy Rivers Corporation (the “Transaction”). The Transaction has now received all final approvals, including that of the TSXV.

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX:WEED, NYSE:CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact: 

Canopy Rivers Inc.

Daniel Pearlstein
Executive Vice President, Strategy
E-mail: ir@canopyrivers.com 

GlobeNewswire
globenewswire.com

Last updated on: 20/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.